Abstract：Objective: To investigate the clinical efficacy and safety of Danhong injection in the treatment of acute cerebral infarction. Methods: 300 patients with acute cerebral infarction who were hospitalized from January 2015 to October 2017 were randomly divided into two groups. Patients in the traditional group were treated with western medicine combined with Danhong injection. Patients in the two groups were compared Symptoms, overall treatment, coagulation, endothelial function and safety. Results: After treatment, the main symptoms in the combined group were significantly lower than those in the traditional group. The total effective rate was significantly higher than that in the traditional group. After treatment, the levels of PT, APTT, 6-keto-PGF1α and NO were significantly different The levels of Fib, D-dimer, ET-1 and TXB2 were significantly lower than those in the traditional group (P<0.01). The blood parameters, liver function and kidney There is no significant difference between the power indicators (P>0.05). Conclusion: Danhong injection has significant clinical effect and high safety in the treatment of acute cerebral infarction.
2019, Vol. 25 
冀公网安备13080202000677号